Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07604207

Multi-organ Imaging of Microvascular and Metabolic Function

What if heart disease starts outside the heart? This research will study how to simultaneously assess brain and body physiology, how they are jointly related to heart function, and how their response to physical and mental stress differs in patients with heart disease.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Early Phase 1

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 18 years and older
  • For patients with cardiovascular disease: Documented diagnosis of ischemic heart disease based on standard clinical, radiologic, and/or histopathologic criteria, as documented in the medical record; or a clinical nuclear cardiac stress PET test within 1 year.
  • For healthy subjects: No diagnosis of cardiometabolic disease, cancer, or other major disease within the past 5 years

Exclusion criteria

  • Contraindications to PET due to:
  • Research-related radiation exposure exceeding current MGB Radiology Department guidelines (i.e., 50 mSv in the prior 12 months);
  • Inability to lie comfortably on the bed inside the scanner;
  • Body weight > 300 lbs (weight limit of the scanner table);
  • Pregnancy or breastfeeding;
  • Individuals with fasting plasma glucose level of >200 mg/dL;
  • Claustrophobia
  • Employed under the direct supervision of the PI conducting the research.

Treatment and study plan

18F-FDG

Drug

Dynamic 18F-FDG PET

Positron emission tomography (PET)

Device

Panorama GS PET/CT

Primary outcomes

  1. Blood flow responses

    Time frame: During the procedure

    The primary endpoint is to evaluate if blood flow responses to acute stressors can be quantitatively measured with 18F-FDG

Secondary outcomes

  1. Glucose metabolism responses

    Time frame: During the scan

    The secondary endpoint is to evaluate if glucose metabolic responses to acute stressors can be quantitatively measured with 18F-FDG

Study contacts

Contact information is provided by the study sponsor or research team.

Kevin J. Chung, PhD

CONTACT

[email protected]

617-724-9232

Sponsors and collaborators

Lead sponsor

Massachusetts General Hospital

Other

Registry information

Important dates

Study start
2026
Primary completion
2031
Study completion
2031
First posted
May 22, 2026
Registry last updated
May 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.